A tumour suppressor in mice and men

Prof. Reinhard Fässler, showed that the transcription factor is helped by a molecular "ticket".

Large numbers of ubiquitin molecules can be attached in sequence to proteins. A certain kind of binding marks this protein as "rubbish" which has to be removed. Another type of ubiquitin attachment to proteins functions as a kind of transport signal. It negotiates the transfer, for example, of proteins into the nucleus. The study shows that this is the case with Bcl-3. It only functions like this, however, when Cyld does not get in the way. This protein was first found in patients suffering from cylindromas. These are tumours that grow on the face, neck, and scalp. Cyld is a deubiquitinase - an enzyme that removes ubiquitin groups from other proteins. "We could show in our study that Cyld proteins can accumulate around the nucleus," says Fässler. "They can intercept Bcl-3 there and prevent it from being imported into the nucleus, by removing ubiquitin appendages." This is the first evidence ever of a specific mechanism that regulates and controls the Bcl-3 oncogene.

The team of researchers from Munich flawlessly reconstructed Cyld interaction with Bcl-3. They demonstrated every step in the process, from the recruiting of Cyld over to the nuclear membrane, to the ubiquitinisation of Bcl-3, and Cyld's reversal of this process. They also showed in detail that Bcl-3 collects without Cyld in the nucleus, and can cause cell proliferation with p50 and p52. All in all, it seems not unlikely that Cyld functions as a tumour suppressor in mice and in humans. In humans, there is evidence that a defective Cyld gene can have negative consequences, like the largely benign tumours of cylindromas. The researchers also found very little, or no, Cyld in the cells of other skin tumours. The situation is similar in some cases of liver, kidney, and uterine cancer. "Cyld is expressed in every cell in the body", Fässler says. "I believe personally that the deubiquitinase activit

Contact: Eva-Maria Diehl

Page: 1 2 3

Related biology news :

1. Research team develops cancer-curing T-lymphocyte-based therapy to eradicate malignant tumours
2. Sick Kids researchers confirm that cancer stem cells initiate and grow brain tumours
3. Multicenter study nets new lung tumor-suppressor gene
4. MicroRNAs can be tumor suppressors
5. MicroRNAs as tumor suppressors
6. Novel regulation of the common tumor suppressor PTEN
7. Tumor-suppressor gene is critical for placenta development
8. Novel regulatory mechanism identified for key tumor suppressor p53
9. A tumor suppressor that promotes cancer cell growth?
10. Structure determined for p53 tumor suppressor protein as bound to DNA for anti-cancer activity
11. Mutation in tumor suppressor gene causes pancreatic islet cells to reproduce

Post Your Comments:
TAG: tumour suppressor mice and men

(Date:9/10/2015)... 10, 2015 Report Details ... Selling Opportunities and Revenue Prospects to Help You ... biologics, especially new drug classes? Get the latest ... with exclusive market data and industry knowledge, benefitting ... results, opportunities and sales predictions. Visiongain,s new ...
(Date:9/8/2015)... Sept. 8, 2015   TREW Marketing and ... survey, Smart Marketing for Engineers TM : Content ... professionals reveals insightful findings about engineers, preferences for online ... content engineers most value and trust, and where they ... targeting technical audiences grapple with how to best implement ...
(Date:9/1/2015)... Sept. 1, 2015  Automation and pre-processing are ... passenger screening. This is the first step toward ... will become unintrusive. An assortment of portal scanners, ... background investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( ...
Breaking Biology News(10 mins):
(Date:10/8/2015)...  Today the Wyss Institute for Biologically Inspired Engineering ... company Opsonix Inc. The announcement follows a ... Technology Development (OTD) and Opsonix Inc. enabling the ... use. --> --> ... every year in the U.S. — more than prostate ...
(Date:10/7/2015)... , October 8, 2015 ... Medical biotechnology accounts for largest bioinformatics ... bioinformatics in drug discovery and development process ... http://www.marketreportshub.com/bioinformatics-industry-research-2020-marketsandmarkets.html . --> ... On the basis of applications, the bioinformatics ...
(Date:10/7/2015)... , Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of targeted ... public offering of 5,000,000 shares of its common stock ... the Company,s common stock at a fixed combined price ... stock and warrants will be issued separately.  The warrants ...
(Date:10/7/2015)... ... October 07, 2015 , ... ... titled Smart Nanostructured Coatings to provide a comprehensive overview of the innovations in ... webinar at http://bit.do/smart-coatings . This webinar will be given by Professor Roberto ...
Breaking Biology Technology:
Cached News: